🌿 Introduction

Quick Facts

Mahonia aquifolium root bark contains the isoquinoline alkaloids berberine and berbamine alongside unique bisbenzylisoquinolines such as mahonine and oxyacanthine, collectively demonstrating antiproliferative effects on keratinocytes that underpin its clinical efficacy in psoriasis, with additional antimicrobial and anti-inflammatory activity mediated through NF-kB inhibition and lipoxygenase suppression. The plant is one of the few botanical agents with randomised controlled trial evidence for moderate-to-severe plaque psoriasis, achieving PASI-75 responses in approximately 40% of patients in the Bernstein 2006 study.

Oregon grape is an evergreen shrub reaching 1-2 metres with pinnately compound, holly-like leaves bearing 5-9 spiny-toothed, glossy dark green leaflets that turn reddish-purple in winter. Dense racemes of small, bright yellow flowers appear in early spring, followed by clusters of blue-black berries with a glaucous bloom resembling small grapes. The inner bark and root bark are bright yellow due to high berberine content. Native to the Pacific Northwest from British Columbia to northern California, the species colonises forest edges, open woodlands, and rocky slopes on well-drained acidic to neutral soils at elevations up to 2,100 metres.

🔍 Identification Guide

Holly-like compound leaves with 5-9 spiny-toothed leaflets distinguish Mahonia from true hollies, which have simple leaves. The bright yellow inner bark and root tissue visible when scraped are diagnostic of berberine-containing species. Dense terminal racemes of yellow flowers in spring and blue-black berry clusters in late summer are characteristic. Leaflets have 10-20 spine-tipped teeth per margin. Distinguish from M. repens by the upright habit (M. repens is stoloniferous and ground-hugging) and from M. nervosa by the number of leaflets (9-19 in M. nervosa versus 5-9 in M. aquifolium).

Plant Anatomy & Medicinal Parts

🧬 Taxonomy & Classification

Taxonomic placement is debated: some authorities merge Mahonia into Berberis based on molecular phylogenetic data, yielding the name Berberis aquifolium. The Flora of North America and most horticultural sources retain Mahonia as a separate genus based on compound (versus simple) leaves and distinct flower morphology. Approximately 70 Mahonia species exist worldwide, with centres of diversity in East Asia and western North America. M. aquifolium hybridises freely with M. repens where ranges overlap, producing intermediate forms.

🧪 Pharmacology & Active Compounds

Berberine (the dominant alkaloid at 2-5% in root bark) inhibits keratinocyte proliferation by blocking cyclin D1 expression and inducing G1 cell cycle arrest, directly relevant to psoriasis pathogenesis. Berbamine suppresses TNF-alpha-induced NF-kB activation in keratinocytes at micromolar concentrations. Oxyacanthine inhibits 5-lipoxygenase, reducing leukotriene B4 synthesis in neutrophils. Jatrorrhizine demonstrates antibacterial activity against Staphylococcus aureus and Propionibacterium acnes with MIC values of 16-64 micrograms/mL. The total alkaloid extract shows antiproliferative effects exceeding those of pure berberine alone, indicating synergy among the alkaloid fraction.

Root bark contains isoquinoline alkaloids totalling 5-10% by dry weight: berberine (2-5%), berbamine (0.5-2%), oxyacanthine (0.3-1.5%), jatrorrhizine (0.2-0.8%), columbamine (0.1-0.5%), and palmatine (0.1-0.4%). The bisbenzylisoquinoline berbamine is characteristic of Mahonia and largely absent from other berberine sources such as Coptis or Hydrastis. Tannins at 3-6% contribute astringency. Berries contain anthocyanins (cyanidin-3-glucoside) but negligible alkaloid content. Seasonal variation is significant, with root bark alkaloid content peaking in autumn after dormancy onset.

Key Active Compounds

Therapeutic Actions

• Antimicrobial
• Anti-Inflammatory
• Cholagogue
• Alterative
• Anti-Psoriatic

⚠️ Safety & Contraindications

Topical preparations are well tolerated with mild transient rash or erythema in about 5% of users, resolving within days without discontinuation. Oral use carries standard berberine cautions: gastrointestinal discomfort at higher doses, uterotonic potential contraindicating use during pregnancy, and bilirubin-displacement risk in neonates. No hepatotoxicity has been reported in clinical trials lasting up to 12 weeks. Berbamine has demonstrated immunosuppressive effects in animal models at high doses, though clinical relevance at topical dermatological doses is negligible. Contact dermatitis from topical application is rare but documented.

Contraindications

Oral preparations contraindicated during pregnancy due to berberine's uterotonic effects and during breastfeeding (bilirubin displacement risk to neonate). Avoid oral use in patients with G6PD deficiency. Topical preparations should not be applied to open wounds deeper than superficial abrasions, as alkaloid absorption through deep wounds is unpredictable. Contraindicated in patients with known allergy to Berberidaceae family plants. Avoid concurrent oral use with immunosuppressants pending further interaction data.

Drug Interactions

Berberine inhibits CYP3A4, CYP2D6, and CYP2C9, potentially increasing plasma levels of cyclosporine, tacrolimus, statins, and warfarin. P-glycoprotein inhibition by berberine increases digoxin bioavailability. Additive hypoglycaemic effects with metformin and sulfonylureas. The immunomodulatory effects of berbamine may theoretically interact with immunosuppressive therapy in transplant patients. Topical-only use largely avoids systemic drug interactions, though absorption through compromised psoriatic skin may be higher than through intact skin.

Drug interactions: cyclosporine (berberine increases levels), CYP2D6/CYP3A4 substrates, antidiabetics (berberine)

🍵 Preparation Methods

Topical ointment (10% bark extract in neutral base) is the primary dermatological preparation, applied twice daily to psoriatic plaques. Tincture of root bark (1:5, 60% ethanol): 1-3 mL three times daily for internal use. Decoction: 3-6 g dried root bark simmered 20-30 minutes. Standardised extract products typically specify 10-12% total alkaloids calculated as berberine. For wound care, powdered root bark is incorporated into salve bases with beeswax and olive oil. The proprietary extract Mahonia Aquifolium 10% cream (Relieva) was used in clinical trials.

Dosage Guidelines

Topical: 10% standardised bark extract cream or ointment applied twice daily to affected areas for 8-12 weeks. Oral tincture: 1-3 mL (1:5, 60% ethanol) three times daily. Oral decoction: 3-6 g dried root bark per day. Standardised oral extract: 250-500 mg (standardised to 10% alkaloids) three times daily. For psoriasis maintenance: topical application once daily after initial clearance. Clinical trial durations have been 4-12 weeks for psoriasis.

Preparation Methods

📜 Traditional Medicine

Native American tribes of the Pacific Northwest used Oregon grape root bark extensively. The Thompson and Okanagan peoples applied root bark decoctions to skin sores, boils, and eczema. The Blackfoot used it as a blood purifier and liver tonic. Lewis and Clark documented its use during the 1805 expedition. Eclectic physicians adopted it in the 1870s for chronic skin diseases, psoriasis, and syphilitic eruptions, considering it a milder alternative to Hydrastis for hepatic and dermatological conditions. The Eclectics specifically noted its affinity for dry, scaly skin conditions.

Traditional Uses

psoriasis, eczema, acne, hepatic congestion, dyspepsia

Energetics: cool, dry

Taste Profile: very bitter

Native Range & Distribution

The map shows the native distribution range of Oregon Grape (origin: Western North America) along with the traditional medicine systems that incorporate this species.

🌱 Cultivation Guide

Hardy evergreen shrub tolerating USDA zones 5-8. Prefers partial shade and acidic, humus-rich, well-drained soil. Full sun exposure intensifies winter leaf colour but may scorch foliage in hot climates. Propagate from seed (requires 90-120 days cold stratification), semi-ripe cuttings in late summer, or division of suckers. Grows slowly, reaching mature size in 5-7 years. Deer-resistant due to alkaloid content. Susceptible to Cumminsiella mirabilissima (Oregon grape rust), a host-specific fungal pathogen causing orange pustules on leaf undersides.

Growing Requirements

✂️ Harvest & Processing

Root bark is harvested from 3-5-year-old plants in autumn when alkaloid content peaks. Dig roots, scrub clean, strip bark while fresh (it becomes brittle when dry). The bright yellow inner bark is the target tissue. Dry at 40-50°C; the bark darkens from yellow to dark brown. Whole roots can be dried and later processed. Stem bark is also usable but contains lower alkaloid concentrations (approximately 60-70% of root bark levels). Store in airtight, light-protected containers; alkaloid content remains stable for 2-3 years.

Harvest Period: autumn to early spring

🔬 Clinical Research

Bernstein et al. (2006) conducted a multicentre RCT of Mahonia aquifolium cream in 200 patients with mild-to-moderate psoriasis, showing significant PASI improvement versus vehicle (p<0.001). Augustin et al. (1999) reported 81% improvement in quality of life with topical Mahonia extract in an open trial of 433 patients. Gieler et al. (1995) demonstrated equivalence to dithranol for plaque psoriasis in a comparative study. Gulliver and Donsky (2005) found the extract effective as maintenance therapy after initial clearance with conventional agents. No trials have been conducted for wound healing specifically.

🤝 Herbal Combinations

Combined with burdock root (Arctium lappa) and red clover (Trifolium pratense) in traditional alterative formulas for chronic skin conditions. With milk thistle (Silybum marianum) for hepatic support alongside dermatological treatment. Paired with nettle leaf (Urtica dioica) for antihistamine support in eczematous presentations. With liquorice root (Glycyrrhiza glabra) for its anti-inflammatory and flavour-balancing properties in oral preparations. Topically combined with calendula and chamomile for enhanced wound-healing and anti-inflammatory effects.

Synergistic Herb Pairs

🏛️ History & Ethnobotany

First described botanically by Frederick Pursh in 1814 from specimens collected during the Lewis and Clark expedition. The genus honours Bernard McMahon, the Philadelphia nurseryman who cultivated the expedition's botanical specimens. Oregon designated M. aquifolium its state flower in 1899. The Eclectic physician John King introduced it to Western materia medica in the 1850s, specifically for scrofulous and syphilitic skin eruptions. European adoption occurred in the 1980s when German phytotherapy researchers investigated its anti-psoriatic potential.

Historical Timeline

📊 Dosage Guidelines

Topical: 10% standardised bark extract cream or ointment applied twice daily to affected areas for 8-12 weeks. Oral tincture: 1-3 mL (1:5, 60% ethanol) three times daily. Oral decoction: 3-6 g dried root bark per day. Standardised oral extract: 250-500 mg (standardised to 10% alkaloids) three times daily. For psoriasis maintenance: topical application once daily after initial clearance. Clinical trial durations have been 4-12 weeks for psoriasis.

🌾 Varieties & Forms

Cultivar 'Compactum' is a dwarf form reaching 60-90 cm, preferred for smaller gardens and easier root bark harvest. 'Apollo' is vigorous with large flower clusters. 'Atropurpureum' has deep reddish-purple winter foliage. M. aquifolium x M. repens hybrids occur naturally in the wild and produce intermediate morphology. The European garden form often sold as M. aquifolium may actually be M. x wagneri, a hybrid of uncertain parentage. M. bealei (leatherleaf mahonia) from China contains similar alkaloids but in different proportions.

⚖️ Regulatory Status

German Commission E approved Mahonia aquifolium bark extract for mild-to-moderate psoriasis. Listed in the European Pharmacopoeia (Mahoniae aquifolii cortex). Not in the USP but available as a dietary supplement and OTC topical product in the US. ESCOP monograph exists for dermatological use. The proprietary topical preparation Relieva received medical device classification in some EU markets. No CITES listing; wild populations are stable throughout the native range.

Legal Status: unrestricted

Conservation Status: least concern

🌱 Beginner's Guide

Start with a commercial 10% Mahonia cream for psoriasis or dry, scaly skin patches — apply to a small test area first and wait 48 hours to rule out contact sensitivity. For internal use, begin with a low-dose tincture (1 mL three times daily) and increase gradually. The root bark tea is intensely bitter; combining with liquorice root improves palatability. Growing Oregon grape in the garden provides a reliable, self-renewing source of root bark after 3-4 years of establishment. Harvest root bark from one side of the plant, allowing recovery before harvesting the other side.

Troubleshooting

Topical redness and mild stinging on first application usually subside within 3-5 days; if it persists or worsens, discontinue and reassess for contact sensitivity. Yellow staining of clothing from berberine is difficult to remove — use old clothing or apply at night. Oral preparations causing nausea should be taken with food and at reduced dose. If psoriasis flares during initial treatment, this may represent a temporary adjustment phase; continue for at least 2 weeks before discontinuing. Lack of response after 8 weeks of topical therapy suggests the preparation's alkaloid content may be subtherapeutic.

Common Mistakes to Avoid

❓ Frequently Asked Questions